Cipaglucosidase alfa 105mg powder for solution for infusion vials

in short Cipaglucosidase alfa 105mg inf vials

SNOMED code
42235011000001109
Active compound
Cipaglucosidase alfa
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Cipaglucosidase alfa — 105 mg based on ingredient substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Pombiliti 105mg powder for concentrate for solution for infusion vials (Amicus Therapeutics UK Operations Ltd)

in short Pombiliti 105mg pdr for concentrate for inf vials

Pombiliti 105mg powder for concentrate for solution for infusion vials

SNOMED code
42231211000001102
Supplier
Amicus Therapeutics UK Operations Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Pombiliti 105mg powder for concentrate for solution for infusion vials (Amicus Therapeutics UK Operations Ltd) 1 vial
42231311000001105   ref. pack
💯 Available

Legal category: POM
05056421000148
NHS Indicative Price
£987
• Hospital
  • • Prescription Charges
Pombiliti 105mg powder for concentrate for solution for infusion vials (Amicus Therapeutics UK Operations Ltd) 10 vial
42732611000001103   ref. pack
💯 Available

Legal category: POM
NHS Indicative Price
£9,870
• Hospital
  • • Prescription Charges

Reference packs

Cipaglucosidase alfa 105mg powder for solution for infusion vials 1 vial
SNOMED code
42231111000001108
Quantity and unit
1 vial
Packs
Cipaglucosidase alfa 105mg powder for solution for infusion vials 10 vial
SNOMED code
42732511000001102
Quantity and unit
10 vial
Packs